Ascent Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Buy |
53,506
+316
| +0.6% | +$14.6K | 0.1% | 195 |
|
|
2025
Q1 | $3.24M | Buy |
53,190
+8,721
| +20% | +$532K | 0.14% | 163 |
|
|
2024
Q4 | $2.52M | Buy |
44,469
+12,227
| +38% | +$692K | 0.19% | 139 |
|
|
2024
Q3 | $1.67M | Buy |
+32,242
| New | +$1.67M | 0.13% | 212 |
|
|
2023
Q2 | – | Sell |
-7,075
| Closed | -$490K | – | 456 |
|
|
2023
Q1 | $490K | Sell |
7,075
-4,065
| -36% | -$282K | 0.05% | 322 |
|
|
2022
Q4 | $801K | Sell |
11,140
-5,352
| -32% | -$385K | 0.09% | 240 |
|
|
2022
Q3 | $1.28M | Buy |
16,492
+4,148
| +34% | +$321K | 0.16% | 180 |
|
|
2022
Q2 | $911K | Buy |
12,344
+243
| +2% | +$17.9K | 0.11% | 219 |
|
|
2022
Q1 | $884K | Buy |
12,101
+2,996
| +33% | +$219K | 0.1% | 232 |
|
|
2021
Q4 | $579K | Buy |
+9,105
| New | +$579K | 0.07% | 277 |
|